Sector
PharmaceuticalsOpen
₹563.55Prev. Close
₹563.1Turnover(Lac.)
₹128.03Day's High
₹570Day's Low
₹56252 Week's High
₹979.552 Week's Low
₹499Book Value
₹337.09Face Value
₹10Mkt Cap (₹ Cr.)
1,130.88P/E
13.74EPS
41.11Divi. Yield
0.3215 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
2 Sep 2024
12:00 AM
AGM
Announcement Date: 02 Sep, 2024
2 Sep 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 20.03 | 20.03 | 20.03 | 20.03 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 572.81 | 482.44 | 412.85 | 346.36 |
Net Worth | 592.84 | 502.47 | 432.88 | 366.39 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Revenue | 376.08 | 324.95 | 304.27 | 310.81 |
yoy growth (%) | 15.73 | 6.79 | -2.1 | 39.21 |
Raw materials | -186.77 | -171.16 | -172.67 | -203.65 |
As % of sales | 49.66 | 52.67 | 56.74 | 65.52 |
Employee costs | -54.89 | -47.5 | -35.05 | -26.73 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Profit before tax | 64.04 | 43.09 | 35.74 | 30.05 |
Depreciation | -5.46 | -4.39 | -3.85 | -3.21 |
Tax paid | -14.48 | -10.34 | -8.33 | -8.31 |
Working capital | -8.51 | 25.15 | 13.34 | -4.84 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.73 | 6.79 | -2.1 | 39.21 |
Op profit growth | 29.17 | 8 | 30.85 | 40.73 |
EBIT growth | 39.41 | 15.08 | 15.61 | 39.5 |
Net profit growth | 51.3 | 19.53 | 26.01 | 47.2 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 623.23 | 580.55 | 510.31 | 472.12 | 424.19 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 623.23 | 580.55 | 510.31 | 472.12 | 424.19 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 22.48 | 34.42 | 22.47 | 10 | 5.66 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Kishorbhai M Shah
Managing Director
Mahendra G Patel
Whole-time Director
Hasmukhbhai I Patel
Whole-time Director
Munjal Mahendrabhai Patel
Whole-time Director
Aashish R Patel
Independent Director
Saurin J Parikh
Non Executive Director
Rajnikant G Patel
Company Sec. & Compli. Officer
Trusha Shah
Independent Director
Seema Mehta
Independent Director
Nareshkumar Pirabhai Suthar
Lincoln House B/H Satyam Compe,
Science City Road Sola,
Gujarat - 380060
Tel: 91-079-67778000
Website: http://www.lincolnpharma.com
Email: [email protected]; [email protected]
5th Floor 506 to 508,
ABC-I Off C G Road, Navrangpura,
Ahmedabad-380009
Tel: 91-79-26465179
Website: https://in.mpms.mufg.com/
Email: [email protected]
Summary
Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converte...
Read More
Reports by Lincoln Pharmaceuticals Ltd
What is the Lincoln Pharmaceuticals Ltd share price today?
What is the Market Cap of Lincoln Pharmaceuticals Ltd?
What is the PE and PB ratio of Lincoln Pharmaceuticals Ltd?
What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?
What is the CAGR of Lincoln Pharmaceuticals Ltd?
What is the shareholding pattern of Lincoln Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.